Generic lamotrigine versus brand‐name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|56|9|1415-1424

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.9, 2015-09, pp. : 1415-1424

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy

By  

EPILEPSIA, Vol. 56, Iss. 6, 2015-06 ,pp. : 915-923

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms

By Meredith Peter A.  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2179-2189

Informa Healthcare

Access to resources Recommend Favorite

Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers

By Baribeault David  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1653-1657

Informa Healthcare

Access to resources Recommend Favorite

Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. : 121-128

John Wiley & Sons Inc

Access to resources Recommend Favorite

P149: Interim analysis for sofosbuvir national treatment program in Egypt

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 94-94

John Wiley & Sons Inc

Access to resources Recommend Favorite